Artal Group’s Lifestance Health LFST Stock Holding History

Artal Group’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-500,000	Closed	-$13.9M	–	153
2021 Q2	$13.9M	Buy	+500,000	New	+$13.2M	0.28%	71

Other funds holding LFST

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Artal Group's LFST Position: Q3 2021 in Review

Artal Group sold out of Lifestance Health (LFST) in Q3 2021, closing a stake of 500,000 shares — an estimated $13.9M sold.

Artal Group first reported a position in LFST in Q2 2021 and held it in 1 quarter. The position peaked at $13.9M in Q2 2021. 69 funds tracked by Wall St. Rank hold LFST as of Q3 2021.

Artal Group reported no remaining Lifestance Health position as of Q3 2021 after selling out during the quarter.
Artal Group sold 500,000 Lifestance Health shares in Q3 2021, an estimated $13.9M.
Artal Group first reported a position in Lifestance Health in Q2 2021 and held it in 1 quarter.
Artal Group's Lifestance Health position peaked at $13.9M in Q2 2021.
69 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2021.

Based on Artal Group's 13F filing for Q3 2021, filed 12 Nov 2021.